Nxera unveils proprietary pipeline targeting obesity and metabolic disorders
6th August 2025 Uncategorised 0
New oral GLP-1 agonist aims to reshape chronic weight management

More: Nxera unveils proprietary pipeline targeting obesity and metabolic disorders
Source: News
